Intestinal barrier function

被引:259
作者
Baumgart, DC [1 ]
Dignass, AU [1 ]
机构
[1] Humboldt Univ, Dept Med, Div Gastroenterol & Hepatol, Charite,Med Ctr Virchow Hosp Med Sch, D-13344 Berlin, Germany
关键词
D O I
10.1097/00075197-200211000-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intestinal barrier function regulates transport and host defense mechanisms at the mucosal interface with the outside world. Transcellular and paracellular fluxes are tightly controlled by membrane pumps, ion channels and tight junctions, adapting permeability to physiological needs. Food and microbial antigens are under constant surveillance of the mucosal immune system. Tolerance against commensals and immunity against pathogens require intact antigen uptake, recognition, processing and response mechanisms. Disturbance at any level, but particularly bacterial translocation due to increased permeability and breakdown of oral tolerance due to compromised epithelial and T cell interaction, can result in inflammation and tissue damage. New therapeutic approaches including probiotics and peptides to restore disrupted barrier function are evolving. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:685 / 694
页数:10
相关论文
共 88 条
[21]   Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes [J].
Feltis, BA ;
Wiesner, SM ;
Kim, AS ;
Erlandsen, SL ;
Lyerly, DL ;
Wilkins, TD ;
Wells, CL .
SHOCK, 2000, 14 (06) :629-634
[22]   Probiotic activities of Lactobacillus casei rhamnosus:: in vitro adherence to intestinal cells and antimicrobial properties [J].
Forestier, C ;
De Champs, C ;
Vatoux, C ;
Joly, B .
RESEARCH IN MICROBIOLOGY, 2001, 152 (02) :167-173
[23]   Induction of necrosis in human neutrophils by Shigella flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization [J].
Francois, M ;
Le Cabec, V ;
Dupont, MA ;
Sansonetti, PJ ;
Maridonneau-Parini, I .
INFECTION AND IMMUNITY, 2000, 68 (03) :1289-1296
[24]   Peyer's patches are required for oral tolerance to proteins [J].
Fujihashi, K ;
Dohi, T ;
Rennert, PD ;
Yamamoto, M ;
Koga, T ;
Kiyono, H ;
McGhee, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3310-3315
[25]   Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia [J].
Furuta, GT ;
Turner, JR ;
Taylor, CT ;
Hershberg, RM ;
Comerford, K ;
Narravula, S ;
Podolsky, DK ;
Colgan, SP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (09) :1027-1034
[26]   Inflammatory bowel disease is associated with changes of enterocytic junctions [J].
Gassler, N ;
Rohr, C ;
Schneider, A ;
Kartenbeck, J ;
Bach, A ;
Overmüller, N ;
Otto, HF ;
Autschbach, F .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (01) :G216-G228
[27]   Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Venturi, A ;
Brigidi, P ;
Matteuzzi, D ;
Bazzocchi, G ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2000, 119 (02) :305-309
[28]  
Godaly G, 2001, J LEUKOCYTE BIOL, V69, P899
[29]   Saccharomyces boulardii in maintenance treatment of Crohn's disease [J].
Guslandi, M ;
Mezzi, G ;
Sorghi, M ;
Testoni, PA .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) :1462-1464
[30]   Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia [J].
Hall, DM ;
Buettner, GR ;
Oberley, LW ;
Xu, LJ ;
Matthes, RD ;
Gisolfi, CV .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (02) :H509-H521